Pharma

About Pharma

India's pharmaceutical sector is the world's pharmacy, producing high-quality medicines at affordable prices for domestic and international markets. The sector benefits from strong scientific talent, cost-effective manufacturing, and robust regulatory approvals. Indian pharma companies manufacture both generic and branded drugs, serving millions globally. The sector has gained prominence due to India's drug discovery capabilities and contract manufacturing services. Export revenues from pharmaceuticals form a significant part of India's pharmaceutical exports to developed nations. Companies invest heavily in research and development to develop new molecules and therapies. The sector saw tailwinds during the pandemic with increased demand for essential medicines and COVID-19 related products. Biosimilars and complex generics are emerging areas of growth. Domestic pharmaceutical consumption is rising with improved healthcare awareness and government health initiatives. The sector faces pricing pressures from regulations and generic competition. Patent expirations create opportunities for generic launches. Healthcare infrastructure development and rising income levels drive domestic demand. Consolidation among mid-sized pharma companies is creating larger players. Regulatory compliance and quality standards remain paramount. The sector is well-positioned to benefit from global healthcare trends and expanding middle class in India.